Vitamin China E-News 1601(12 issues per year)

Date: 2016-02

“Domestic food industry is entering into rapid-transformation period. The demand for healthy and nutritious products is growing. The R&D and innovation capability of healthy and nutritious products will determine the development outcomes of enterprises.
In 2015, VC market price remains low, but it is unlikely to rise. It’s estimated that VC price will maintain stable or edge down at the beginning of 2016, under the background of serious overcapacity.
Due to the intensive production, massive imported meats and strengthened industry supervision, large amount of small feed manufacturers withdrew from the market, so the total number of Chinese feed manufacturers is decreasing year by year.
In 2015, China’s pharmaceutical industry experienced a slowdown in its growth, which can be attributed to the increasingly rigid governmental supervision and more and more fierce competition. However, a slowdown in growth doesn’t indicate industry decline, but it is an opportunity of transformation and upgrading for the overall pharmaceutical industry instead.
At then end of Dec. 2015, a strategic partnership agreement was signed between CSPC and the Xingtai municipal government Hebei Province. They planned to build an important bio-pharmaceutical base in Xingtai City for CSPC in three to five years, meanwhile this base will contribute to Xingtai’s economic development.
Second Pharma gained the pharmaceutical trading license for nicotinamide API, which was issued by Taiwan’s Food and Drug Administration of the Sanitation and Welfare Department. This license allows its sales in Taiwan and exerts a positive impact on the company’s future development.
Garden Bio-chemical recorded a sharp fall in financial performance in 2015, negatively impacted by sluggish VD3 markets in home and abroad and cholesterol production shutdown & upgrading.
In Nov. 2015, China’s export volume of VB12 and its derivatives soared month on month, mainly because a continual fall of domestic VB12 price stimulated foreign clients’ desire to purchase.
VB2 price is likely to rise in Q1 2016, which would be a continuation of the price trend in Q4 2015. This is due to the declining supply.
In Jan. 2016, the supply of spot VA is tight and the quotations of VA from distributors are high. It’s estimated that VA price will be on the rise.”

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample